South San Francisco, CA, United States of America

Jie Xu

This inventor holds 7 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Xu. Retrieved from https://idiyas.com/inventor/jie-xu-vl0rcboy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 85.7

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 11.7

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

South San Francisco, CA (US) (2021 - 2023)
San Mateo, CA (US) (2024)

Company Filing History:

Hoffmann-La Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698284 - SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE (2026-08-04),

2. 12448386 - Processes for the preparation of substituted 1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indoles (2025-10-21),

3. 12172982 - Synthesis of quinazoline compounds (2024-12-24),

4. 12071422 - Process for synthesis of quinazoline compounds (2024-08-27),

5. 11873305 - Processes for synthesis of substituted indole intermediates for the synthesis of serd compounds (2024-01-16),

6. 11780834 - Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use (2023-10-10),

7. 10954234 - Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use (2021-03-23),

Title: Jie Xu: Innovator in Pharmaceutical Chemistry

Introduction

Jie Xu is a prominent inventor based in South San Francisco, CA, known for his contributions to pharmaceutical chemistry. With a total of 7 patents, he has made significant strides in the development of innovative compounds and processes.

Latest Patents

Among his latest patents is a process for the preparation of substituted 1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indoles. This patent outlines methods utilizing Wenker-Synthesis aimed at synthesizing GDC-9545. Additionally, he has developed methods for synthesizing quinazoline compounds that include at least one atropisomeric center.

Career Highlights

Jie Xu has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His work has contributed to advancements in drug development and synthesis techniques.

Collaborations

Throughout his career, Jie has collaborated with esteemed colleagues such as Haiming Zhang and Francis Gosselin, further enhancing his innovative contributions to the field.

Conclusion

Jie Xu's work in pharmaceutical chemistry exemplifies the impact of innovation in drug development. His patents and collaborations reflect a commitment to advancing the science of medicinal chemistry.

Profile summary based on public USPTO records.